Emerging Therapeutics and Drug Development

Emerging Therapeutics and Drug Development explores the latest innovations in pharmaceutical research, novel antidiabetic agents, hormone-based therapies, biologics, and targeted treatments for endocrine disorders. Discussions will review clinical trial outcomes, regulatory considerations, patient access, and future therapeutic directions. Participants will gain insights into cutting-edge drug development that supports safer, more effective, and personalised endocrine care.

  • Novel Antidiabetic Agents
  • Hormone-Based Therapies
  • Biologics and Targeted Treatments
  • Clinical Trials

    Related Conference of Emerging Therapeutics and Drug Development

    July 20-21, 2026

    6th World Congress on Endocrine and Diabetes

    Paris, France
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France
    October 20-21, 2026

    32nd World Diabetes & Heart Congress

    Amsterdam, Netherlands
    October 22-23, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    February 25-26, 2027

    20th International Summit on Diabetes

    London, UK
    March 23-24, 2027

    7th Annual Summit on Diabetes and Endocrinology

    Paris, France
    March 29-30, 2027

    8th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands

    Emerging Therapeutics and Drug Development Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in